Should Biotechnology Stock Lexaria Bioscience Corp (LEXX) Be in Your Portfolio Monday?

A rating of 82 puts Lexaria Bioscience Corp (LEXX) near the top of the Biotechnology industry according to InvestorsObserver. Lexaria Bioscience Corp's score of 82 means it scores higher than 82% of stocks in the industry. Lexaria Bioscience Corp also received an overall rating of 65, putting it above 65% of all stocks. Biotechnology is ranked 53 out of the 148 industries.

LEXX has an Overall Score of 65. Find out what this means to you and get the rest of the rankings on LEXX!

See Full LEXX Report

What do These Ratings Mean?

Analyzing stocks can be hard. There are tons of numbers and ratios, and it can be hard to remember what they all mean and what counts as “good” for a given value. InvestorsObserver ranks stocks on eight different metrics. We percentile rank most of our scores to make it easy for investors to understand. A score of 65 means the stock is more attractive than 65 percent of stocks. These scores are not only easy to understand, but it is easy to compare stocks to each other. You can find the best stock in an industry, or look for the sector that has the highest average score. The overall score is a combination of technical and fundamental factors that serves as a good starting point when analyzing a stock. Traders and investors with different goals may have different goals and will want to consider other factors than just the headline number before making any investment decisions.

What's Happening With Lexaria Bioscience Corp Stock Today?

Lexaria Bioscience Corp (LEXX) stock has gained 29.77% while the S&P 500 is down -0.04% as of 1:29 PM on Monday, Nov 27. LEXX is higher by $0.39 from the previous closing price of $1.31 on volume of 451,829 shares. Over the past year the S&P 500 has risen 14.98% while LEXX is down -30.33%. LEXX lost -$1.13 per share the over the last 12 months. Click Here to get the full Stock Report for Lexaria Bioscience Corp stock.